A R T I C L E S
Barbera´ et al.
Given the possibilities that metal coordination offers to
molecular design, we have been using it as a means to achieve
molecular shapes capable of organizing into chiral superstruc-
tures. Previous studies were based on discotic metal â-diketo-
nates that showed a rectangular columnar mesophase whose
helical structure was extensively studied, as well as its ferro-
electric behavior.11 The origin of the supramolecular chirality
in these systems was the presence of stereogenic centers in the
peripheral tails (derived from (S)-lactic acid) in the molecule.
Recently, we considered the possibility of inducing the
transfer of chirality from the rigid part of the molecule to the
supramolecular organization in the mesophase. Previous work
carried out in our group on aryloxazolines derived from (S)-â-
amino alcohols demonstrated the great potential of this type of
compounds in the design of mesogenic structures that display
chiral mesophases. For example, SmC* ferroelectric mesophases
with high Ps values were obtained when the chiral oxazoline
moiety was linked to the appropriate mesogenic core.12 Further
work was undertaken based on the ability of phenyloxazolines
to coordinate to metals. Planar mesogenic complexes were
obtained that induced broad cholesteric ranges when used as
chiral dopants in nematic hosts.13
Figure 1. Chemical structure of the polycatenar palladium(II) (Pd(S-C12)2)
and copper(II) (Cu(S-C12)2) oxazoline complexes.
symmetry, with its binary axis perpendicular to the coordination
plane. This arrangement causes the two methyl groups in the
stereogenic centers to lie on the same side of the molecular
plane. Both complexes have been deeply investigated by X-ray
diffraction and circular dichroism in order to elucidate the
possible helical organization in the mesophase. Taking into
account the geometry of the molecule and the strong influence
of both stereogenic centers in the intermolecular interactions,
we decided to go deeper into the study of supramolecular
organization. Our aim was to assess the influence of both aspects
on the supramolecular organization and also to answer an
intriguing question: Does the helical organization maintain in
the mesophase of the nonoptically active mixtures [Pd(S-C12)2
+ Pd(R-C12)2 and Pd(RS-C12)2]?. For this reason, we extended
our investigation to the enantiomeric complex as well as to
nonoptically active mixtures of complexes. Thus, the enantiomer
Pd(R-C12)2, the racemic mixture, Pd(S-C12)2 + Pd(R-C12)2, and
the palladium(II) complex of the racemic ligand (resulting in a
diastereomeric mixture, Pd(RS-C12)2) were prepared. Palladium-
(II) derivatives were chosen for this study according of
preliminary results that indicated the possibility of producing
well-aligned samples of the palladium(II) complex, Pd(S-C12)2.
Furthermore, palladium(II) complexes yield higher diffraction
intensities due to the presence of the heavier palladium atom.
Studies have recently been expanded to encompass different
mesogenic structures, such as elongated polycatenar molecules
(phasmidic-like) that can give rise to columnar mesomorphism.14
As a first attempt to obtain chiral columnar systems from
aryloxazolines, chiral ligands were prepared derived from 3,4,5-
trialkoxybenzoic acid. Complexation of these ligands with
copper(II) or palladium(II) yielded planar phasmidic-like com-
plexes that did not show mesomorphic behavior unless an
electron acceptor such as TNF was added in certain proportions.
These complexes were, however, shown to have high helical
twisting powers in appropriate nematic hosts.15
On the basis of these results, and in order to achieve
polycatenar metallomesogens that are able to induce helical
columnar organizations, we have designed a new oxazoline-
derived ligand with an extended aromatic core and six dodecyl-
oxy terminal chains. Coordination to palladium(II) or copper(II)
results in phasmidic-like planar complexes, i.e., Pd(S-C12)2 and
Cu(S-C12)2 (Figure 1). X-ray studies of related chiral oxazoline
complexes have demonstrated that upon complexation only the
trans isomer is formed.16 Hence, the molecule should have C2
Results and Discussion
Synthesis.17 The synthetic pathway for all the compounds is
outlined in Scheme 1. The synthesis of the enantiomeric and
racemic 4,5-dihydro-2-(2′,4′-dihydroxyphenyl)-4-methyloxazole
(1) was carried out as reported previously.12 The corresponding
starting (S)-, (R)- and (RS)- amino alcohols were purchased from
Aldrich. The 3,5-bis(3,4,5-tridodecyloxybenzoyloxy)benzoic
acid (4) was prepared by esterification of benzyl 3,5-dihydroxy-
benzoate (3) with 2 equiv of 3,4,5-tridodecyloxybenzoyl chloride
(2). The synthesis of 3 was carried out through a solid-state
phase-transfer reaction between the potassium salt of 3,5-
dihydroxybenzoic acid and benzylbromide, catalyzed by tetra-
butylammonium chloride following the method described by
Keller.18
(8) (a) Verbiest, T.; van Elshocht, S.; Kauranen, M.; Hellemans, L.; Snauwaert,
J.; Nuckolls, C.; Katz, T. J.; Persoons, A. Science 1998, 282, 913-915.
(b) Fox, J. M.; Katz, T. J.; van Elshocht, S.; Verbiest, T.; Kauranen, M.;
Persoons, A.; Thongpanchang, T.; Krauss, T.; Brus, L. J. Am. Chem. Soc.
1999, 121, 3453-3459.
(9) (a) Bock, H.; Helfrich, W. Liq. Cryst. 1992, 12, 697-703. (b) Bock, H.;
Helfrich, W. Liq. Cryst. 1995, 18, 387-399. (c) Bock, H.; Helfrich, W.
Liq. Cryst. 1995, 18, 707-713. (d) Heppke, G.; Kru¨erke, D.; Mu¨ller, M.;
Bock, H. Ferroelectrics 1996, 179, 203-209. (e) Scherowsky, G.; Chen,
X. H. Liq. Cryst. 1994, 17, 803-810. (f) Scherowsky, G.; Chen, X. H. J.
Mater. Chem. 1995, 5, 417-421. (g) Kru¨erke, D.; Rudquist, P.; Lagerwall,
S. T.; Sawade, H.; Heppke, G. Ferroelectrics 2000, 243, 207-220.
(10) Nuckolls, C.; Shao, R.; Jang, W. G.; Clark, N. A.; Walba, D. M.; Katz, T.
J. Chem. Mater. 2002, 14, 773-776.
(11) (a) Barbera´, J.; Iglesias, R.; Serrano, J.; Sierra, T.; de la Fuente, M. R.;
Palacios, B.; Pe´rez-Jubindo, M. A. J. Am. Chem. Soc. 1998, 120, 2908-
2918. (b) Serrano, J. L.; Sierra, T. Chem. Eur. J. 2000, 6, 759-766.
(12) Serrano, J. L.; Sierra, T.; Gonza´lez, Y.; Bolm, C.; Weickhardt, K.; Magnus,
A.; Moll, G. J. Am. Chem. Soc. 1995, 13, 4374-4381.
(13) Lehmann, M.; Marcos, M.; Serrano, J. L.; Sierra, T.; Bolm, C.; Weickhardt,
K.; Magnus, A.; Moll, G. Chem. Mater. 2001, 117, 8312-8321.
(14) Nguyen, H. T.; Ch. Destrade; Maltheˆte, J. AdV. Mater. 1997, 9, 375-388.
(15) Lehmann, M.; Sierra, T.; Barbera´, J.; Serrano, J. L.; Parker, R. J. Mater.
Chem. 2002, 12, 1342-1350.
(16) Go´mez-Simo´n, M.; Jansat, S.; Muller, G.; Panyella, D.; Font-Bad´ıa, M.;
Solans, X. J. Chem. Soc., Dalton Trans. 1997, 3755-3764.
1
Ligands and complexes were identified by H NMR, 13C
NMR, FT-IR, and elemental analysis. The 1H NMR spectra of
both enantiomeric complexes show that only one isomer is
(17) See Supporting Information.
(18) Keller, P.; Hardouin, F.; Mauzac, M.; Achard, M. F. Mol. Cryst. Liq. Cryst.
1988, 155, 171-178.
9
4528 J. AM. CHEM. SOC. VOL. 125, NO. 15, 2003